Donna Harrison, M.D.
Associate ScholarDr. Donna Harrison is a physician, board-certified in obstetrics and gynecology for 30 years. She is currently serving as Director of Research for the American Association of Pro-Life Obstetricians and Gynecologists, the largest non-sectarian pro-life physician organization in the world, with over 7,000 members across the United States, and associate members on every continent.
Dr. Harrison’s research interests include selective progesterone receptor modulators, endometrial contraception, maternal mortality, and abortion mortality and morbidity. She has authored peer reviewed papers on maternal mortality, mifepristone mortality and morbidity, the approval of mifepristone and ulipristal (Ella) as well as other topics concerning endometrial contraception. Dr. Harrison is a Continuing Medical Education Speaker in the United States and internationally on topics of Medical Abortion with Mifepristone and Misoprostol, Adverse Events associated with Mifepristone and Misoprostol, Emergency Contraception with Ulipristal, Maternal Mortality, and Abortion Morbidity.
She is an Adjunct Professor at Trinity International University in Deerfield, IL, teaching post graduate seminars at the annual Center for Bio Ethics and Human Dignity summer workshops. She is Associate Editor of the peer reviewed medical journal “Issues in Law and Medicine.”
Dr. Harrison is married to Dr. Mark Harrison, M.D., and is the mother of 5 children and 5 grandchildren.
Research Authored
Improving the Metrics and Data Reporting for Maternal Mortality: A Challenge to Public Health Surveillance and Effective Prevention
The current measuring metric and reporting methods for assessing maternal mortality are seriously flawed. Evidence-based prevention strategies require consistently reported surveillance data and validated measurement metrics.
Doctors Who Perform Abortions: Their Characteristics and Patterns of Holding and Using Hospital Privileges
Controversy exists regarding whether doctors who perform abortions should be required to hold hospital admitting privileges, but no research exists as to the extent to which they actually hold and use such privileges.
Abortion Pill Reversal: A Second Chance at Choice
National Academies Report Downplays the Health Risks of Abortion
Earlier this month, the National Academies of Sciences, Engineering, and Medicine (NAS) released a report on the safety of abortion in the United States. It examines various methods used for abortion and concludes that abortion is safe and poses minimal health risks. The report also puts a negative spin on pro-life laws, arguing that many of them have no basis in medical research, and states that some abortion-specific regulations create barriers to safe health care.
Rewire’s Reckless Push for Mail-Order Mifeprex
In pursuit of the possibility that abortion drugs could be distributed via pharmacies or mail order shipment for at-home use, researchers from a group called Gynuity Health Projects sought RU-486 online from 20 websites and had them tested for their potency – that is, whether they contained enough of the drugs in the two-step regimen to effectuate an abortion.
Abortion Increases Risk of Preterm Birth: More Evidence in New Publication
The recent systematic review published by Gabrielle Saccone and colleagues joins the long list of over 150 studies over the past four decades which extensively document that having an induced abortion increases a woman’s risk of preterm birth in subsequent pregnancies.
Good News for Pregnant Moms Diagnosed with Cancer, and Good News for their Unborn Babies
Separation of a mother and her unborn child is tragically sometimes necessary to save the life of the mother. But the number of conditions which truly threaten the mother’s life, and which require a life-saving separation of the mother and her baby are vanishingly small. A new study by Amant and colleagues, entitled “Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy,” brings tremendous hope to pregnant women who have courageously carried their unborn children to birth, despite the need for chemotherapy or radiation therapy.